Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

CVS Health

Dollar General

Dollar Tree

Ralph Lauren

Ross Stores

Walmart

The economy is booming, but that doesn't mean you can expect retail stocks to take off. Some of them are running into some challenges.

7 Retail Stocks That You Don't Want In Your Cart

Allscripts Healthcare Solutions

NextGen Healthcare Inc

Stocks like CVS Health (CVS), Walgreens Boots Alliance (WBA) and Allscripts (MDRX) are expected to continue to grow post-pandemic on a series of remote health care product and service launches.

3 Stocks With Telehealth Offerings for Post-Pandemic Gains

Apple

Salesforce

Cisco Systems

Goldman Sachs

Home Depot

Inhibrx Biosciences Inc

Intel

Coca-Cola

McDonald's

Microsoft

NIKE

ReneSola

UnitedHealth Group

Two new sample breakout stocks for Week 24 with better than 10% short-term upside potential. This past week the peak gains were in LIZI +28.9% and LQDT +10.3% with all 4 picks giving back gains to the Friday close on higher negative MG® conditions.

Week 24 MDA Breakout Stocks - June 2021: Short-Term Picks To Give You An Edge

Franklin Resources

Cincinnati Financial

Community Trust Bancorp

Con Ed

Federal Realty Investment Trust

Johnson & Johnson

Kimberly-Clark

Altria

Northwest Natural Gas

Old Republic International

Procter & Gamble

SJW Group

Telephone and Data Systems

United Bankshares

Universal Corp

V.F.

Drip Investing lists over 800 stocks that have annually increased dividends for 5 years or more. These 66 June stocks boosting dividends 40 years and more were parsed from 139 Champions posted 5/28/21. These 66 select dividend stocks ranged 0.70% to 6.86% in annual yield and ranged -8.12% to 30.72% in annual price target upside estimates per brokers sampled 6/10/21.

June's 40-Year-Plus Annual Dividend Boosters

It's definitely not good news for the big pharmacy retailers.

Are CVS and Walgreens in Trouble if Amazon Enters the Retail Pharmacy Market?

Covid-19 vaccination is increasing foot traffic leading to higher sales and margins, and the recovery from the pandemic is removing the root cause of negative earnings. Walgreens' cost savings initiative and its Village Medical strategy will grow sales margins after the Covid-19 recovery.

Walgreens Boosts Alliance: 45% Upside Ahead

Walgreens Boots Alliance Inc. said Thursday that starting June 11, its 4,000 pharmacy locations will extend hours for walk-in COVID-19 vaccinations for the next three Fridays. The drug store chain also has 400 pharmacy locations that are open 24 hours.

Walgreens to extend pharmacy hours for the next 3 Fridays for walk-in COVID-19 vaccinations

The larger your investment is and the longer you hold it, the more money you could be missing out on -- if you're investing in income stocks that don't raise their payouts.

Not Buying Dividend Growth Stocks? Here's How Much Money You're Losing

DEERFIELD, Ill.--(BUSINESS WIRE)--As part of the Biden Administration's National Month of Action, Walgreens will extend pharmacy hours of operation each Friday in June to provide those who may have limited time the additional flexibility needed to get a COVID-19 vaccine. On Friday, June 11, 18 and 25, 4,000 Walgreens pharmacy locations will extend hours of operation for walk-in vaccinations. Individuals can visit Walgreens online store locator or call their local Walgreens to check for updated

Walgreens Continues to Boost COVID-19 Vaccination Access Across the Country

Lizhi

Newpark Resources

Travelers

Two new sample breakout stocks for Week 23 with better than 10% short-term upside potential. This past week, the peak gains were in RMO +17.4% and NNDM +10.8% with all 4 picks gaining more than +5% in less than 5 days.

Week 23 MDA Breakout Stocks - June 2021: Short-Term Picks To Give You An Edge

Walgreens (WBA) will increase focus on core retail pharmacy business and bring better healthcare offerings to patients and customers with the divestment.

Walgreens (WBA) Divests Alliance Healthcare Business for $6.5B

DEERFIELD, Ill.--(BUSINESS WIRE)---- $WBA--Walgreens Boots Alliance will release its fiscal 2021 third quarter earnings results at 7 a.m. Eastern time Thursday, July 1, 2021.

Walgreens Boots Alliance Schedules Fiscal 2021 Third Quarter Earnings Announcement for July 1, 2021

AmerisourceBergen

The large drug wholesaler AmerisourceBergen completed its acquisition of the majority of Walgreens Boots Alliance's “Alliance Healthcare” wholesale distribution business for $6.5 billion.

Walgreens Completes $6.5B Sale Of European Distribution Business To AmerisourceBergen

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced it has completed the sale of its Alliance Healthcare businesses to AmerisourceBergen.

Walgreens Boots Alliance Completes Strategic Transaction with AmerisourceBergen Divesting Alliance Healthcare Businesses

Walgreens Boots' (WBA) response toward combatting the pandemic - conducting COVID-19 tests at various locations and actively participating in vaccinating residents and staff - is impressive.

Walgreens' (WBA) New Partnerships Aid, Retail Sales Dip

Chevron

Polaris

Philip Morris

RenaissanceRe Hlds

SEI Investments

1st Source

The 8 Best Dividend Aristocrats You Can Buy With The Market At Record Highs

Himax Tech

Nano Dimension

Two new sample breakout stocks for Week 22 with better than 10% short-term upside potential. This past week the portfolio gained +4.4% led by gains in CDEV +15.6% and 3 out of 4 picks gaining more than +6.2% in less than 5 days.

Week 22 MDA Breakout Stocks - June 2021: Short-Term Picks To Give You An Edge

The stock price of Walgreens Boots Alliance has seen a 5% drop over the last five trading days, and we believe that the stock will underperform the broader markets in the near term. Much of the recent decline came on May 26, after reports of Amazon eyeing brick and mortar pharmacy stores.

Here's Why Walgreens Stock May Underperform In The Near Term

Aurora Acquisition Corp

Social Capital Hedosophia Holdings Corp. V

JPMorgan Chase & Co

AT&T

Upstart Holdings

U.S. Bancorp

Verizon

Wells Fargo

Here are some of the top stories around the financial sector that investors need to know.

Upstart Impresses, and Banks Get Creative Giving Credit

Rite Aid

CVS (NYSE: CVS), Walgreens (NASDAQ: WBA) and Rite Aid (NYSE: RAD) shares lost ground Wednesday after a Business Insider report that Amazon (NASDAQ: AMZN) is considering entering the physical pharmacy retail space. The story's three unnamed sources, who were not authorized to speak to the press, said there is no concrete plan, but rather exploratory discussions are taking place.

CVS, Walgreens, Rite Aid Shares Fall On Report Of Potential Amazon Entry Into Retail Pharmacy

News for Walgreens Stock (WBA)